-
rp174879-500μgRANK ligand
-
R647893-10mgRBN013209 is a potent CD38 inhibitor with an IC 50 of 0.01-0.1 μM for human CD38. RBN013209 can be used for the research of of cancer.Form:Solid
-
R647893-5mgRBN013209 is a potent CD38 inhibitor with an IC 50 of 0.01-0.1 μM for human CD38. RBN013209 can be used for the research of of cancer.Form:Solid
-
R655211-1mlRBN013209 is a potent CD38 inhibitor with an IC 50 of 0.01-0.1 μM for human CD38. RBN013209 can be used for the research of of cancer.
-
S650551-1mgSolitomab (AMG 110) is a bispecific anti-CD3 and anti-epithelial-cell-adhesion-molecule (EpCAM) antibody. Solitomab can be used for the research of primary uterine and ovarian carcinosarcoma cancer.In VitroSolitomab (1 μg/mL 4 hours) shows
-
S650551-5mgSolitomab (AMG 110) is a bispecific anti-CD3 and anti-epithelial-cell-adhesion-molecule (EpCAM) antibody. Solitomab can be used for the research of primary uterine and ovarian carcinosarcoma cancer.In VitroSolitomab (1 μg/mL 4 hours) shows
-
-
-
rp175374-1mgvascular cell adhesion protein 1
-
rp175374-500μgvascular cell adhesion protein 1